Evidence map›Paper›PMID 30081484›Full record

ArticleInternational journal of environmental research and public health2018

Recommendations for Improving the Quality of Rare Disease Registries.

Yllka Kodra, Jérôme Weinbach, Manuel Posada-de-la-Paz, Alessio Coi, S Lydie Lemonnier, David van Enckevort, Marco Roos, Annika Jacobsen, Ronald Cornet, S Faisal Ahmed and 19 more

Abstract readConsensus Statement
In one paragraph

Article in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. The Minimum Data Set for Rare Diseases: Systematic Review.Journal of medical Internet research · 2023
    Pooled it
  3. Development of a framework to assess the quality of data sources in healthcare settings.Journal of the American Medical Informatics Association : JAMIA · 2022
    Pooled it
  4. Trial
  5. Review
  6. Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2026
    Review
  7. Review
  8. Patient Outcomes Among Medicare Beneficiaries With Guillain-Barré Syndrome.Journal of the peripheral nervous system : JPNS · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. The RaDiCo information system for rare disease cohorts.Orphanet journal of rare diseases · 2025
    Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Yllka KodraNational Centre for Rare Diseases, Istituto Superiore di Sanità, 00162 Rome, Italy. yllka.kodra@iss.it.
Jérôme WeinbachRaDiCo, (The French National Programme on Rare Disease Cohorts), Inserm-UMR S933, National Institute of Health and Medical Research, Hôpital Trousseau, 75018 Paris, France. jerome.weinbach@radico.fr.
Manuel Posada-de-la-PazInstitute of Rare Diseases Research, ISCIII, RDR and CIBERER, 28029 Madrid, Spain. mposada@isciii.es.ORCID 0000-0002-8372-4180
Alessio CoiInstitute of Clinical Physiology, National Research Council, 56124 Pisa, Italy. alessio.coi@ifc.cnr.it.ORCID 0000-0002-9816-3144
S Lydie LemonnierPatient Advisory Council of RD Connect and Vaincre la Mucoviscidose the French Cystic Fibrosis Patient Organization, 75013 Paris, France. llemonnier@vaincrelamuco.org.
David van EnckevortDepartment of Genetics, University Medical Centre Groningen (UMCG), University of Groningen, 9700 RB Groningen, The Netherlands. d.van.enckevort@rug.nl.ORCID 0000-0002-2440-3993
Marco RoosLeiden University Medical Center, 2333 ZA Leiden, The Netherlands. m.roos@lumc.nl.
Annika JacobsenLeiden University Medical Center, 2333 ZA Leiden, The Netherlands. annika.jacobsen.86@gmail.com.ORCID 0000-0003-4818-2360
Ronald CornetAmsterdam UMC, University of Amsterdam, Medical Informatics, Amsterdam Public Health Research Institute, 1105 AZ Amsterdam, The Netherlands. r.cornet@amc.uva.nl.ORCID 0000-0002-1704-5980
S Faisal AhmedOffice for Rare Conditions, Royal Hospital for Children, University of Glasgow, Glasgow G51 4TF, UK. faisal.ahmed@glasgow.ac.uk.
Virginie Bros-FacerPatient Advisory Council of RD-Connect and EURORDIS-Rare Diseases Europe, 75014 Paris, France. virginie.bros-facer@eurordis.org.
Veronica PopaPatient Advisory Council of RD Connect and MCT8-AHDS Foundation, Oklahoma, OK 74464, USA. veronica_maria_popa@yahoo.com.
Marieke Van MeelPatient Advisory Council of RD Connect and NephcEurope Foundation, 2411 DW Bodegraven, The Netherlands. mvanmeel@casema.nl.
Daniel RenaultPatient Advisory Council of RD Connect and FEDERG, 1200 Brussels, Belgium. daniel.renault34@orange.fr.
Rainald von GizyckiPatient Advisory Council of RD Connect and PRO RETINA Deutschland, 53113 Bonn, Germany. rainald.vongizycki@charite.de.
Michele SantoroInstitute of Clinical Physiology, National Research Council, 56124 Pisa, Italy. msantoro@ifc.cnr.it.
Paul LandaisRaDiCo, (The French National Programme on Rare Disease Cohorts), Inserm-UMR S933, National Institute of Health and Medical Research, Hôpital Trousseau, 75018 Paris, France. paul.landais@umontpellier.fr.
Paola TorreriNational Centre for Rare Diseases, Istituto Superiore di Sanità, 00162 Rome, Italy. paola.torreri@iss.it.
Claudio CartaNational Centre for Rare Diseases, Istituto Superiore di Sanità, 00162 Rome, Italy. claudio.carta@iss.it.
Deborah MascalzoniDepartment of Public Health and Caring Sciences, Centre for Research Ethics & Bioethics (CRB) Uppsala University, 75122 Uppsala, Sweden. deborah.mascalzoni@crb.uu.se.
Sabina GainottiBioethics Unit, Office of the President, Istituto Superiore di Sanità, 00162 Rome, Italy. sabina.gainotti@iss.it.ORCID 0000-0002-6006-9064
Estrella LopezInstitute of Rare Diseases Research, ISCIII, RDR and CIBERER, 28029 Madrid, Spain. elopez@isciii.es.ORCID 0000-0003-3212-1424
Anna AmbrosiniFondazione Telethon, 20129 Milan, Italy. aambrosini@telethon.it.
Heimo MüllerDiagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, 8010 Graz, Austria. heimo.mueller@medunigraz.at.
Robert ReisDiagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, 8010 Graz, Austria. robert.reihs@medunigraz.at.
Fabrizio BianchiInstitute of Clinical Physiology, National Research Council, 56124 Pisa, Italy. fabrizio.bianchi@ifc.cnr.it.
Yaffa R RubinsteinNational Library of Medicine/National Institutes of Health, Bethesda, MD 20892-2128, USA. yaffa.rubinstein@nih.gov.
Hanns LochmüllerDepartment of Neuropediatrics and Muscle Disorders Medical Center, University of Freiburg Faculty of Medicine, 79160 Freiburg, Germany. hanns.lochmuller@gmail.com.
Domenica TaruscioNational Centre for Rare Diseases, Istituto Superiore di Sanità, 00162 Rome, Italy. domenica.taruscio@iss.it.ORCID 0000-0001-5403-233X

Funding

Medical Research Council MR/N003403/1
6 · The paper itself

Abstract

Rare diseases (RD) patient registries are powerful instruments that help develop clinical research, facilitate the planning of appropriate clinical trials, improve patient care, and support healthcare management. They constitute a key information system that supports the activities of European Reference Networks (ERNs) on rare diseases. A rapid proliferation of RD registries has occurred during the last years and there is a need to develop guidance for the minimum requirements, recommendations and standards necessary to maintain a high-quality registry. In response to these heterogeneities, in the framework of RD-Connect, a European platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research, we report on a list of recommendations, developed by a group of experts, including members of patient organizations, to be used as a framework for improving the quality of RD registries. This list includes aspects of governance, Findable, Accessible, Interoperable and Reusable (FAIR) data and information, infrastructure, documentation, training, and quality audit. The list is intended to be used by established as well as new RD registries. Further work includes the development of a toolkit to enable continuous assessment and improvement of their organizational and data quality.

Indexed as

Quality ImprovementRare DiseasesBiomedical ResearchComputational BiologyData AccuracyEuropeHumansInformation Storage and RetrievalRegistriespatient registryqualityrare diseases

Identifiers

PMID30081484
PMCPMC6121483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.